Adaptive Biotechnologies (ADPT) Institutional Ownership
13F filers reported holding 100.5% of Adaptive Biotechnologies (ADPT) shares as of Jun 30, 2026, across 304 filers.
4 figures withheld by our checks. Each blank figure names its reason.
- Held by 13F filers
- 100.5%
- Jun 30, 2026
- 13F filers
- 304
- quarter ended Jun 30, 2026
- 13F value
- $3.5B
- 162.6M shares
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | RUBINSTEIN JULIE | President and COO | Acquired · Option exercise | 11,466 | $12.14 | ↗ |
| Nov 13, 2026 | RUBINSTEIN JULIE | President and COO | Disposed · Open-market sale | 11,466 | $28.93 | ↗ |
| Nov 13, 2026 | RUBINSTEIN JULIE | President and COO | Disposed · Option exercise | 11,466Stock Option (right to buy) | — | ↗ |
| Nov 12, 2026 | RUBINSTEIN JULIE | President and COO | Acquired · Option exercise | 11,881 | $12.14 | ↗ |
| Nov 12, 2026 | RUBINSTEIN JULIE | President and COO | Disposed · Open-market sale | 11,881 | $29.40 | ↗ |
| Nov 12, 2026 | RUBINSTEIN JULIE | President and COO | Disposed · Option exercise | 11,881Stock Option (right to buy) | — | ↗ |
| Nov 11, 2026 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Disposed · Open-market sale | 1,875 | $32.00 | ↗ |
| Nov 11, 2026 | RUBINSTEIN JULIE | President and COO | Acquired · Option exercise | 11,881 | $12.14 | ↗ |
| Nov 11, 2026 | RUBINSTEIN JULIE | President and COO | Disposed · Open-market sale | 4,983 | $30.29 | ↗ |
| Nov 11, 2026 | RUBINSTEIN JULIE | President and COO | Disposed · Open-market sale | 6,898 | $31.22 | ↗ |
| Nov 11, 2026 | RUBINSTEIN JULIE | President and COO | Disposed · Option exercise | 11,881Stock Option (right to buy) | — | ↗ |
| Nov 9, 2026 | ROBINS CHAD M | CEO and Chairman | Disposed · Gift | 100,000 | — | ↗ |
| Nov 6, 2026 | RUBINSTEIN JULIE | President and COO | Acquired · Option exercise | 11,881 | $12.14 | ↗ |
| Nov 6, 2026 | RUBINSTEIN JULIE | President and COO | Disposed · Open-market sale | 8,400 | $27.32 | ↗ |
| Nov 6, 2026 | RUBINSTEIN JULIE | President and COO | Disposed · Open-market sale | 3,481 | $27.88 | ↗ |
| Nov 6, 2026 | RUBINSTEIN JULIE | President and COO | Disposed · Option exercise | 11,881Stock Option (right to buy) | — | ↗ |
| Nov 5, 2026 | RUBINSTEIN JULIE | President and COO | Acquired · Option exercise | 11,881 | $12.14 | ↗ |
| Nov 5, 2026 | RUBINSTEIN JULIE | President and COO | Disposed · Open-market sale | 5,926 | $26.10 | ↗ |
| Nov 5, 2026 | RUBINSTEIN JULIE | President and COO | Disposed · Open-market sale | 5,455 | $26.88 | ↗ |
| Nov 5, 2026 | RUBINSTEIN JULIE | President and COO | Disposed · Open-market sale | 500 | $27.70 | ↗ |
* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Adaptive Biotechnologies do institutions hold?
13F filers reported holding 100.5% of Adaptive Biotechnologies' shares as of Jun 30, 2026, across 304 filers.
How many 13F filers hold Adaptive Biotechnologies?
Adaptive Biotechnologies was held by 304 13F filers as of Jun 30, 2026.
Not investment advice.

